Oral Cavity Cancer · Symptoms & diagnosis

How is oral cavity cancer diagnosed and staged?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Oral Cavity Cancer Answer length: short, citable
Quick answer

Diagnosis requires a tissue biopsy read by a head and neck pathologist, supported by endoscopic examination and contrast CT or MRI of the neck; PET-CT is added when nodal or distant spread is suspected. Staging uses the AJCC TNM system and guides whether surgery, radiotherapy, chemoradiotherapy or systemic therapy is the primary treatment.

In detail

AJCC 8th edition TNM for oral cavity cancer incorporates depth of invasion (DOI) into the T category, because thicker tumours have a higher risk of occult neck metastasis. This is why even a clinically node-negative tongue cancer with DOI above 3–4 mm often receives an elective neck dissection or sentinel lymph node biopsy.

Before radiotherapy, guidelines recommend a dental assessment and extraction of teeth with a poor prognosis inside the radiation field. Ask for this early: it prevents osteoradionecrosis later.

  • Incisional biopsy of the suspicious lesion — the only way to confirm invasive cancer
  • Bimanual palpation and measurement of the lesion, with photography for the record
  • Contrast CT or MRI of the oral cavity and neck to assess bone invasion, tongue muscle involvement and nodes
  • Ultrasound-guided FNA of any suspicious cervical node; chest CT / PET-CT for advanced disease
  • Dental panoramic radiograph, dental clearance and nutritional assessment before surgery or radiotherapy
  • Pathology review for depth of invasion, margins, perineural invasion, lymphovascular invasion and extranodal extension

What this means in practice: this answer is part of the “Symptoms & diagnosis” section of the Oral Cavity Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about oral cavity cancer

See all 15 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  3. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  4. Oral cancer burden and mortality in India: a GLOBOCAN 2022 analysis with regional comparison ecancermedicalscience · 2026 · 143,759 new oral cancer cases and 79,979 deaths in India in 2022.
  5. Smokeless Tobacco and Oral Cancer in Global Perspective New England Journal of Medicine · 2026 · More than 360 million users of smokeless tobacco; ~120,000 oral cancer cases attributable to smokeless tobacco, areca nut or both in 2022.
  6. Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy PubMed Central / peer-reviewed review · 2026

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.